RETRACTION: Melatonin Modulates Dysregulated Circadian Clocks in Mice With Diethylnitrosamine-Induced Hepatocellular

    PubMed
    Abstract

    Insights

    This study on melatonin and liver cancer in mice was retracted due to duplicated figures, impacting data interpretation. The authors dispute this decision, highlighting concerns over image duplication and data integrity in scientific research.

    Area of Science:

    • Hepatocellular carcinoma research
    • Circadian clock regulation
    • Melatonin's biological effects

    Context:

    • Concerns raised regarding data duplication in Figures 1C and 3C.
    • Duplication identified between Figure 1C and another publication by the same authors.
    • Figure 3C also contained internal duplications.

    Purpose:

    • To investigate the role of melatonin in modulating circadian clock dysregulation in diethylnitrosamine-induced hepatocellular carcinoma in mice.
    • To assess the impact of melatonin on liver cancer progression and associated clock pathway alterations.

    Summary:

    • The article investigating melatonin's effects on circadian clocks in mice with hepatocellular carcinoma has been retracted.
    • Retraction due to concerns over duplicated figures (1C and 3C) and insufficient original data provided by authors.
    • Concerns about figure duplication affected the interpretation of presented data and results.

    Impact:

    • Undermines the reliability of findings on melatonin and liver cancer.
    • Highlights the importance of rigorous data verification in scientific publishing.
    • Raises questions about the integrity of research involving circadian clock modulation and cancer.